Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
In a randomization of women with early-stage breast cancer, researchers explored the potential benefits of chemotherapy for women whose Oncotype DX RS was midrange.
Diagnosis & Disease Information
Oncotype DX Recurrence Score a Potential Marker of Hereditary Breast Cancer
Researchers conducted a review of more than 400 patients with hormone receptor-positive breast cancer to determine if high Oncotype DX RS is associated with a greater likelihood the cancer is hereditary.
Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
Research presented at SABCS 2017 demonstrated the effect of refining the linear predictor for determining which patients with breast cancer would potentially benefit from adjuvant chemotherapy.
Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
Study findings presented at SABCS 2017 demonstrate that intermediate Oncotype DX scores are prognostic of overall survival for patients with early-stage breast cancer, particularly in younger women with the disease.
- Loading...
Loading...
Next post in SABCS 2017
Loading... 
Loading...